Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 10 studies | 25% ± 9% |
Insufficient scRNA-seq data for expression of NAT1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 99% | 186.71 | 354 / 359 | 97% | 9.71 | 277 / 286 |
breast | 100% | 203.80 | 459 / 459 | 94% | 178.85 | 1055 / 1118 |
intestine | 95% | 366.90 | 919 / 966 | 99% | 9.66 | 520 / 527 |
kidney | 100% | 218.60 | 89 / 89 | 91% | 4.65 | 817 / 901 |
lung | 93% | 254.02 | 540 / 578 | 95% | 7.38 | 1096 / 1155 |
ovary | 98% | 92.51 | 177 / 180 | 90% | 4.94 | 385 / 430 |
bladder | 95% | 109.95 | 20 / 21 | 92% | 6.42 | 465 / 504 |
pancreas | 94% | 89.06 | 309 / 328 | 92% | 5.78 | 163 / 178 |
esophagus | 94% | 115.77 | 1355 / 1445 | 89% | 6.55 | 163 / 183 |
uterus | 95% | 127.78 | 161 / 170 | 86% | 6.75 | 394 / 459 |
liver | 99% | 500.53 | 223 / 226 | 78% | 3.81 | 317 / 406 |
prostate | 100% | 383.58 | 245 / 245 | 76% | 8.82 | 381 / 502 |
skin | 90% | 159.48 | 1630 / 1809 | 79% | 4.12 | 374 / 472 |
thymus | 97% | 116.48 | 634 / 653 | 72% | 2.95 | 436 / 605 |
adrenal gland | 96% | 127.53 | 248 / 258 | 40% | 1.78 | 92 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 7.06 | 29 / 29 |
spleen | 100% | 275.22 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 140.49 | 1198 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 5.61 | 44 / 45 |
heart | 90% | 88.34 | 777 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 87% | 98.28 | 1167 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 75% | 228.84 | 693 / 929 | 0% | 0 | 0 / 0 |
brain | 31% | 16.26 | 824 / 2642 | 38% | 1.41 | 265 / 705 |
eye | 0% | 0 | 0 / 0 | 69% | 2.55 | 55 / 80 |
muscle | 7% | 2.80 | 55 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0004060 | Molecular function | arylamine N-acetyltransferase activity |
Gene name | NAT1 |
Protein name | Arylamine N-acetyltransferase 1 (EC 2.3.1.5) (Arylamide acetylase 1) (Monomorphic arylamine N-acetyltransferase) (MNAT) (N-acetyltransferase type 1) (NAT-1) arylamine N-acetyltransferase (EC 2.3.1.5) Arylamine N-acetyltranserase 1 (EC 2.3.1.5) (Arylamine N-acetyltransferase) |
Synonyms | AAC1 |
Description | FUNCTION: Participates in the detoxification of a plethora of hydrazine and arylamine drugs. Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens. |
Accessions | Q9HAQ5 P18440 F5H5R8 ENST00000545197.3 Q400J6 ENST00000518029.5 ENST00000517492.5 ENST00000307719.9 ENST00000520546.1 Q400I9 Q6U7I7 Q5C8V2 |